Literature DB >> 21512226

Macrophage mediated anti-proliferation effects of Anthodia camphorata non-polysaccharide based extracts on human hepatoma cells.

Chia-Yu Chang1, Tain-Junn Cheng, Fang-Rong Chang, Hsien-Yi Wang, Wei-Chih Kan, Shun-Lai Li, Li-Hsueh Huang, Yu-Chun Chen, Wan-Chen Tsai, Chia-Hsin Huang, Chia-Hui Cheng, Guo-Yang Lee, Shiang-Wei Shyue, Yi-Peng Chen, Kao-Chang Lin, Jiunn-Jye Chuu.   

Abstract

It has been reported that medicinal mushrooms might induce different types of immune responses. Anthodia camphorata (A. camphorata) has attracted much attention for its therapeutic effects in treating hepatoma. We tested this anti-tumor effects using immunomodulation of macrophages and extracts of A. camphorata. We evaluated the anti-proliferation effects of various extracts of A. camphorata from fruiting bodies (AC-FB), mycelium of solid-state cultures (AC-SS), liquid-state cultures (AC-LS) and polyaccharide extracts from liquid-state cultures (AC-PS), and extracts of A. camphorata stimulated RAW 264.7 macrophage cell-conditioned mediums (MC-CMs). We measured cell proliferation and, did migration assays by cell cycle analysis and by observing apoptosis-related proteins (AKT, PARP-1, and NF-κB) and the mRNA expression of cytokines (TNF-α and IL-1β) of macrophages in human hepatoma cell lines. Our results revealed that two of the extracts (AC-FB and AC-SS) had better anti-proliferation effects, implying an immunomodulatory role the macrophages might play. This outcome is consistent with findings that AC-FB and AC-SS increase mRNA expression of TNF-α and the corresponding expression of apoptosis-related proteins on activation of MC-CMs, while A. camphorata polysaccharides induce macrophage-derived anti-tumor activities in human hepatoma cells via IL-1β and Akt activation. These results indicate that anti-tumor effects exerted by modulation of macrophage activation of A. camphorate may be influenced by the other constituents which (contained little or no polysaccharide) of A. camphorata.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512226     DOI: 10.1271/bbb.100559

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Dendrimer-Based Nanomedicine (Paramagnetic Nanoparticle, Nanocombretastatin, Nanocurcumin) for Glioblastoma Multiforme Imaging and Therapy.

Authors:  Stephen L Brown; James M Snyder; Meser M Ali
Journal:  Nov Approaches Cancer Study       Date:  2021-10-20

2.  Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways.

Authors:  Ali S Arbab; Meser M Ali
Journal:  Nov Approaches Cancer Study       Date:  2020-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.